title: Use of recombinant interleukin-2 for intrapleural therapy of tumor-associated pleurisy.
abstract: Clinical efficiency of low dose Roncoleukin was studied in 30 patients with metastatic exudative pleurisy. Intrapleural therapy proved to be highly effective (overall effect reached 84%), was well tolerated, and improved patients' quality of life.
authors.affiliation: NN Blokhin Cancer Research Center, Russian Academy of Medical Sciences, Moscow, Russia. ks-titov@mail.ru
authors.forename: K S
authors.initials: KS
authors.lastname: Titov
authors.forename: M V
authors.initials: MV
authors.lastname: Kiselevskii
authors.forename: L V
authors.initials: LV
authors.lastname: Demidov
authors.forename: I N
authors.initials: IN
authors.lastname: Mikhailova
authors.forename: I Zh
authors.initials: IZh
authors.lastname: Shubina
authors.forename: L M
authors.initials: LM
authors.lastname: Rodionova
authors.forename: I E
authors.initials: IE
authors.lastname: Sinel'nikov
authors.forename: K Yu
authors.initials: KY
authors.lastname: Topol'
authors.forename: A N
authors.initials: AN
authors.lastname: Gritsai
mesh_terms: D000328:Adult; D000368:Aged; D005260:Female; D006801:Humans; D016130:Immunophenotyping; D015552:Injections, Intralesional; D007376:Interleukin-2 / Q000008:administration & dosage / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000150:complications / Q000473:pathology; D010998:Pleurisy / Q000188:drug therapy / Q000209:etiology; D016896:Treatment Outcome
chemical_list: D007376:Interleukin-2